1Cleem JL. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel detection, evaluation, and treatment ol high blood cholesterol in adults (adult treatment panel Ⅲ ) [J]. JAMA, 2001,285 (19) : 2486- 2497.
3Greenland P, Abrams J, Aurigemma GP, et al. Prevention Conference V: Beyond secondary prevention: Identifying the high-risk patient for primary prevention:Noninvasive tests of atherosclerotic burden : Writing GroupⅢ [J ]. Circulation, 2000, 101 ( 1 ) : 16 - 22.
4Duprez D. Hope brings hope for the use of the ankle-braehial index as cardiovascular risk marker[J]. Eur Heart J,2004,25 (1) : 1 -2.
5Resnick HE, Lindsay RS, McDermott MM, et al. Relationship of high and low ankle-braehial index to all-cause and cardiovascular disease mortality: The Strong Heart Study[J]. Circulation, 2004,109 (6) : 733- 739.
6Suominen V,Rantanen T, Venermo M, et al. Prevalence and risk factors of PAD among patients with elevated ABI[J]. Eur J Vase Endovasc Surg,2008,35(6) :709-714.
7American Diabetes Association. Peripheral arterial disease in people with diabetes[J]. Diabetes Care,2003,26(12):3333-3341.
8Hooi J D,Kester AD, Stoffers HE,et al. Asymptomatic peripheral arterial occlusive disease predicted cardiovascular morbidity and motality in a 7-year-follow-up study[J].J Clin Epidemiol, 2004,57(3):294-300.
9Wikstrom J, Hansen t,Johansson L, et al. Ankle brachial index < 0.9 underestimates the prevalence of peripheral artery occlucive diseases assessed with whole-body magnetic response angiography in the elderly[J]. Acta Radiol,2008,49(2) :143-149.
10Guo X,Li J,Pang W,et al. Sensitivity and specificity of ankle- brachial index for detecting angiographic stenosis of peripheral arteries[J]. Cite J ,2008,72(4) : 605- 610.
2Hiatt WR . Medical treatment of peripheral arterial disease and claudication[J]. N Engl Med, 2001,344:1608-21.
3Dieter RS, Chu WW, Pacanowski JP, et al . The significance of lower extremity peripheral disease [J]. Clin Cardiol,2002; 25:3-10.
4Hirsch AT, Criqui MH, Treat-Jacobson D, et al. Peripheral arterial disease detection, awareness, and treatment in primary care[J]. JAMA, 2001,286:1317-24.
5Criqui MH ,Langer RD, Fronek A, et al. Mortality over a period of 10 years in patients with peripheral arterial disease [J].N Eng J Med,1992,326:381-386.
6TASC Working Group. Management of peripheral arterial disease[J]. J Vasc Surg, 2003,31( 1 suppl ):S1-S296.
7Leng GC, Papacosta O, Whincup P, et al. femoral atherosclerosis in an old British population: prevalence and risk factors[J]. Atherosclerosis ,2002,152:167-74.
8Djousse L, Levy D, Murabito JM, et al. Alcohol consumption and risk of intermittent claudication in the Framingham Heart Study[J].Circulation ,2002,102:3092-97.
9Christian K, Gottfeied R. The challenges of treating peripheral disease [J].Vas Med, 2003,8:109-114.
10Antiplatelet trialists' Collaboration. Collaborative overview of randomized trials of antiplatelet therapy.1:Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients[J].BMJ,1994, 308:81-106.
